DOI: 10.1055/s-00000071

Seminars in Neurology


Hauser SL, Comi GC, Hartung HP , et al.
Efficacy and safety of ocrelizumab in relapsing multiple sclerosis—results of the phase III double-blind, interferon beta-1a controlled OPERA I and II studies.
Presented at: 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis; October 9, 2015; Barcelona, Spain

Download Bibliographical Data

Search in: